Signant Health and Propeller Health are connecting their systems to help improve asthma and chronic obstructive pulmonary disease (COPD) patients’ adherence to inhaled medication and symptom control. Signant said it will connect its TrialMax electronic clinical outcome assessment (eCOA) platform to Propeller’s digital health platform for…
A newly developed assisted breathing device, based on the principles of older mechanical respirators but with more convenience and power, may soon be available for people with lung diseases who have trouble breathing. The Right Air vest is a small, powerful device to assist breathing that can be used…
The use of Propeller Health’s digital health program, which integrates real-time data from chronic obstructive pulmonary disease (COPD) patients and feedback from healthcare providers, had a significant improvement on health outcomes, a new study shows. The study, “Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in…
The overall efficacy and safety profile of erdosteine is superior to other commonly used mucolytic agents for the treatment of chronic obstructive pulmonary disease (COPD), a new study shows. The study, “Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across…
AstraZeneca’s triple combination therapy Breztri Aerosphere, formerly known as PT010, has been approved in Japan for the treatment of symptoms of chronic obstructive pulmonary disease (COPD). This makes Japan the first country to grant regulatory approval for Breztri Aerosphere. Breztri Aerosphere, which is composed of budesonide, glycopyrronium…
Physicians at Illinois’ Northwestern Memorial Hospital are the first in the United States to successfully perform a robotic-assisted lung volume reduction surgery (LVRS) to extract diseased tissue from the lungs of patients with severe emphysema, a progressive form of chronic obstructive pulmonary disease (COPD). The first procedure was done in late…
The COPD Foundation has launched an app called the COPD Pocket Consultant Guide (PCG), designed to help healthcare providers in the treatment and management of patients with chronic obstructive pulmonary disease (COPD). Links to download the app, either for Android or iOS, can be found here. The main features…
Patients with chronic obstructive pulmonary disease (COPD) on long-term treatment with benzodiazepines are at a higher risk for suicide, a study suggests. The study, “Risks of Benzodiazepines in Chronic Obstructive Pulmonary Disease with Comorbid Posttraumatic Stress Disorder,” was published in the journal Annals of the American Thoracic Society.
Testosterone replacement therapy can help slow the progression of chronic obstructive pulmonary disease (COPD) in men, a new study shows. Men with COPD tend to experience shortness of breath, leading physicians to prescribe them long-term steroid-based medications. While these medications help treat pulmonary symptoms, they are also associated with…
Digital health company Adherium recently launched the Hailie solution in the U.S., a technology designed to help patients with asthma and chronic obstructive pulmonary disease (COPD) track their medication usage and better manage their condition. This follows a 510(k) over-the-counter clearance from the U.S. Food and Drug Administration that allows…
Get regular updates to your inbox.